"I think the biggest challenge that patients face is the fact that they have a highly visible condition that others around them just don't understand," Dr. Harvey Lui says.
A panelist discusses how new data from the 2025 American Academy of Dermatology Annual Meeting (AAD 2025) demonstrates tildrakizumab’s efficacy in treating nail psoriasis, with the 100-mg dose showing ...
With so much hype around these medications and their ability to get rid of belly fat, you may wonder how a weight loss drug can treat a skin condition. One connection provides a clue: If you have ...
FDA Grants Priority Review to Zasocitinib for Psoriasis Zasocitinib is also being evaluated in phase 3 studies for psoriatic arthritis and in phase 2 studies for Crohn’s disease, ulcerative colitis, ...
Shop the best Prime Big Deal Days skin care sales of 2026, with deals on editor-tested retinol, sunscreen, eye creams, LED face masks, and more.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results